ePSMI for Pancreatic Cancer

Overseen By Sara Fleszar-Pavlovic, PhD

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: University of Miami

Disqualifiers: Severe psychiatric illness, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

Duration: 10 weeks

60 Participants Needed

Trial Summary

Do I need to stop my current medications to join the trial?

The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial organizers or your doctor.

What is the purpose of this trial?

The purpose of this research is to evaluate a new, web-based program among patients with pancreatic cancer aimed at reducing psychosocial stress.

Research Team

Frank Penedo, PhD

Principal Investigator

University of Miami

Eligibility Criteria

This trial is for adults over 18 who have been diagnosed with pancreatic cancer, including those with a specific type called PNET. Participants must be able to read Spanish or English. It's not suitable for individuals with severe psychiatric conditions or any issue that might interfere with their participation as judged by the study leader.

Inclusion Criteria

I can speak and read either Spanish or English.

I am over 18 years old.

I have been diagnosed with pancreatic cancer.

Exclusion Criteria

Any condition that, in the opinion of the investigator, would compromise the well-being of the patient or the study or prevent the patient from meeting or performing study requirements

I have not had severe psychiatric issues or hospitalizations for them in the last year.

I can read and understand either Spanish or English.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive the ePSMI intervention, a web-based program aimed at reducing psychosocial stress, for up to ten weeks

10 weeks

Biweekly calls

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Long-term follow-up

Participants are monitored for recruitment, participation, and retention rates, as well as disease progression and other long-term outcomes

1 year

Treatment Details

Interventions

• ePSMI

Trial Overview The trial is testing ePSMI, a web-based program designed to help reduce stress in patients dealing with pancreatic cancer. The effectiveness of this online tool will be evaluated through participant feedback and assessments.

Participant Groups

Group I: ePSMI Group Experimental Treatment 1 Intervention

Participants in this group will receive the ePSMI intervention for up to ten weeks.

Who Is Running the Clinical Trial?

University of Miami

Lead Sponsor

Trials

976

Recruited

423,000+

U.S. Army Medical Research and Development Command

Collaborator

Trials

296

Recruited

249,000+